Last10K.com

Aehr Test Systems (AEHR) SEC Filing 10-Q Quarterly Report for the period ending Monday, February 28, 2022

Aehr Test Systems

CIK: 1040470 Ticker: AEHR

EXHIBIT 99.1

 

 

 

FOR IMMEDIATE RELEASE              

 

Contacts:

 

Aehr Test Systems

MKR Investor Relations Inc.

Ken Spink

Chief Financial Officer

(510) 623-9400 x309

Todd Kehrli or Jim Byers

Analyst/Investor Contact

(323) 468-2300

aehr@mkr-group.com

  

Aehr Reports Record Revenue in Third Quarter on Wafer Test and Burn-in Sales

 Driven by the Demand for Electric Vehicles

 

Fremont, CA (March 31, 2022)

– Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced financial results for its third quarter of fiscal 2022 ended February 28, 2022.

 

Fiscal Third Quarter Financial Results:

 

 

·

Net sales were $15.3 million, up 190% from $5.3 million in the third quarter of fiscal 2021.

 

·

GAAP net income was $2.2 million, or $0.08 per diluted share compared to a GAAP net loss of $735,000, or $0.03 per diluted share, in the third quarter of fiscal 2021.

 

·

Non-GAAP net income was $4.1 million, or $0.14 per diluted share, which excludes the impact of $880,000 stock-based compensation and a $1.0 million adjustment for excess and obsolete inventory related to legacy products. This compares to a non-GAAP net loss of $360,000, or $0.02 per diluted share, which excludes the impact of $271,000 stock-based compensation in the third quarter of fiscal 2021.

 

·

Bookings were $6.0 million for the quarter ended February 28, 2022.

 

·

Backlog as of February 28, 2022 was $26.9 million. Effective backlog, which includes all orders announced since the end of the third quarter, is over $30 million.

 

Fiscal First Nine Months Financial Results:

 

 

·

Net sales were $30.5 million, up 241% from $9.0 million in the first nine months of fiscal 2021.

 

·

GAAP net income was $3.7 million, or $0.13 per diluted share. This compares to a GAAP net loss of $2.6 million, or $0.11 per diluted share, in the first nine months of fiscal 2021.

 

·

Non-GAAP net income was $5.2 million, or $0.19 per diluted share, which excludes the impact of stock-based compensation, the adjustment for excess and obsolete inventory and forgiveness of the PPP loan. This compares to a non-GAAP net loss of $4.1 million, or $0.17 per diluted share, in the first nine months of fiscal 2021, which excludes the impact of stock-based compensation and the net gain related to the closure of Aehr’s Japan subsidiary during the first quarter of fiscal 2021.

 

An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr’s non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.

 

 

 

 

Aehr Test Systems Reports Third Quarter Fiscal 2022 Financial Results

March 31, 2022

Page 2 of 7

  

Gayn Erickson, President and CEO of Aehr Test Systems, commented:

 

“We finished the quarter with revenue of $15.3 million, our highest quarterly revenue on record, non-GAAP net income of $4.1 million, and a strong backlog of $26.9 million at quarter end. Our effective backlog, which includes all orders announced since the end of the third quarter, is over $30 million.

 

“We continue to see very strong interest and demand for wafer level test and burn-in of silicon carbide devices and see enormous growth potential for silicon carbide semiconductor test and burn-in to support the world-wide electrification movement in electric vehicles, power conversion, and power generation and storage infrastructure.

 

“During the quarter, four additional companies provided detailed wafer layouts to Aehr for their silicon carbide wafers, as part of their evaluation of using Aehr’s FOX-XPTM systems and WaferPakTM contactors for wafer level burn-in of their devices to meet the electric vehicle market and electrification infrastructure markets. We have provided those customers with the data confirming that we believe we can test their wafers and provide proposals and lead times to meet their needs. This includes another major supplier of silicon carbide devices who has now committed to an on-wafer benchmark and asked us to put a system on their test floor to demonstrate our capabilities. This is now the second of the top silicon carbide customers (beyond our current lead silicon carbide customer) to engage with us in what we call on-wafer benchmarking of their actual wafers.

 

“We have now made several proposals to customers to place orders to lock in lead times of our FOXTM systems and WaferPaks, and Aehr will provide on-wafer evaluations and validations for them within the lead time of the systems. In just the last few weeks, we met with multiple companies in both the US and Europe and are very encouraged by the positive feedback we received about their forecasts for wafer level burn-in needs and our expectations for winning this capacity with these prospective customers. This included very productive meetings with a major supplier of silicon carbide that is currently doing on wafer benchmarking and burn-in optimization investigations with our FOX system and WaferPaks today. It is apparent that wafer level burn-in will become the standard for silicon carbide devices, and based upon customer feedback, we continue to believe that Aehr is unique in our ability to meet the cost and volume production needs of this market.

 

“We continue to work closely with our lead silicon carbide test and burn-in customer, and earlier this month we announced follow-on orders from them for additional WaferPakTM Contactors that reflect multiple new silicon carbide device designs they are building to be qualified by their customers, along with several silicon carbide devices now qualified and ramping into production to meet demand for electric vehicles. This customer forecasts the need for additional systems to meet their goal of achieving a major share of the silicon carbide market. We continue to expect significant additional system and WaferPak purchases from them over the next several years and through the end of the decade.

 

“Forecasts from Canaccord Genuity estimate that the silicon carbide market for devices in electric vehicles, such as traction inverters and on-board chargers, as well as off-board charging stations used for electric vehicle charging, is expected to grow from fewer than 150,000 6-inch equivalent wafers of capacity in 2022 to more than four million wafers in 2030 to meet the more than 30 million electric vehicles anticipated to be built per year by then. This projected demand for just the electric vehicle silicon carbide wafers represents at least a $1 billion market opportunity for our wafer level test and burn-in systems and consumables over the next eight years. Canaccord also forecasts an additional capacity need of more than four million silicon carbide wafers to meet demand in 2030 for electrification infrastructure, industrial, and photovoltaic power devices. In our recent customer visits, we are now seeing demand surface for the wafer level burn-in of silicon carbide devices beyond electric vehicles that we believe is likely to become a significant market opportunity for Aehr as well.   

 

 

 

 

Aehr Test Systems Reports Third Quarter Fiscal 2022 Financial Results

March 31, 2022

Page 3 of 7

  

“We are also seeing continued recovery and strengthening in the silicon photonics test and burn-in market, reflecting the post-Covid recovery that is driving devices to meet 5G and data center infrastructure build out. Several customers addressing the silicon photonics market have forecast additional FOXTM system and WaferPak or DiePak® contactor capacity needs over the next 12 months.

 

“In addition to the silicon carbide and silicon photonics markets that are strong drivers of our business, during the quarter we received an initial order from a current FOX-XP customer for our proprietary DiePak Carriers for a new optical sensor device, representing a new application for our FOX-XP system. This customer is a supplier of sensors to a major mobile device, personal computer, and consumer electronics manufacturer. This is the first order of DiePaks for this device, which is expected to move to production and will require additional DiePak Carriers and may also require additional FOX-XP system production capacity.

 

“We are excited about the unprecedented inbound interest and expanding growth opportunities we are seeing with a significant number of new potential customers that are evaluating the unique capabilities and cost effectiveness of our FOX-XP multi-wafer test and burn in system for their test and burn-in needs. We remain very focused on serving several large market opportunities we see ahead.”

 

Fiscal 2022 Financial Guidance:

 

For the fiscal year ending May 31, 2022, Aehr is reiterating its previously provided guidance for full year total revenue of at least $50 million, and to be profitable for the fiscal year at these revenue levels based upon its operating model.

 

Management Conference Call and Webcast

 

Aehr Test Systems will host a conference call and webcast today at 5:00 p.m. Eastern (2:00 p.m. PT) to discuss its third quarter fiscal 2022 operating results. To access the live call, dial 888-204-4368 (US and Canada) or +1 929-477-0402 (International) and give the participant passcode 7607624. In addition, a live and archived webcast of the conference call will be available over the Internet at www.aehr.com in the Investor Relations section and at the following link https://edge.media-server.com/mmc/p/am93aopv. A replay of the conference call will also be available via telephone beginning approximately two hours after conclusion of the call through 8:00 p.m. ET on April 7, 2022. To access the replay dial-in information, please click here.

 

About Aehr Test Systems

 

Headquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr Test products in package, wafer level, and singulated die/module level test. Aehr Test has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The ABTS system is used in production and qualification testing of packaged parts for both lower power and higher power logic devices as well as all common types of memory devices. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems used for burn-in and functional test of complex devices, such as leading-edge memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices. The FOX-CP system is a new low-cost single-wafer compact test and reliability verification solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The WaferPak Contactor contains a unique full wafer probe card capable of testing wafers up to 300mm that enables IC manufacturers to perform test and burn-in of full wafers on Aehr Test FOX systems. The DiePak Carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of both bare die and modules. For more information, please visit Aehr Test Systems’ website at www.aehr.com.

 

 

 

 

Aehr Test Systems Reports Third Quarter Fiscal 2022 Financial Results

March 31, 2022

Page 4 of 7

  

Safe Harbor Statement

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr’s future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates,” “going to,” "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," “sees,” or "continue," or the negative of these words or other similar terms or expressions that concern Aehr’s expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, Aehr’s ability to generate bookings and revenue increases in the future, including the first quarter of fiscal 2022; future requirements and orders of Aehr’s new and existing customers; bookings forecasted for proprietary WaferPakTM and DiePak consumables across multiple market segments; the temporary nature of customer pushouts; shipping timelines for products and follow-on capacity orders; the growth of Aehr’s systems and consumables, including as a percentage of total sales; financial guidance for fiscal 2022, including related to revenue and profitability, and expectations regarding fiscal 2022; Aehr’s ability to expand its number of customers using its FOX-PTM solutions; the ability to secure potential customer engagements; expectations related to long-term demand for Aehr’s productions and  the attractiveness of key markets; the belief that Aehr will be stronger after the current worldwide COVID-19 pandemic, including expectations related to greater production, more customers, more applications, and higher value products. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr’s recent 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.

 

Financial Tables to Follow –

 

 

 

 

Aehr Test Systems Reports Third Quarter Fiscal 2022 Financial Results

March 31, 2022

Page 5 of 7

  

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

Feb 28,

 

 

Nov 30,

 

 

Feb 28,

 

 

Feb 28,

 

 

Feb 28,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$ 15,283

 

 

$ 9,611

 

 

$ 5,267

 

 

$ 30,540

 

 

$ 8,962

 

Cost of sales

 

 

8,886

 

 

 

5,092

 

 

 

3,373

 

 

 

17,343

 

 

 

6,464

 

Gross profit

 

 

6,397

 

 

 

4,519

 

 

 

1,894

 

 

 

13,197

 

 

 

2,498

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

2,612

 

 

 

2,489

 

 

 

1,643

 

 

 

7,054

 

 

 

4,658

 

Research and development

 

 

1,529

 

 

 

1,313

 

 

 

903

 

 

 

4,163

 

 

 

2,623

 

Total operating expenses

 

 

4,141

 

 

 

3,802

 

 

 

2,546

 

 

 

11,217

 

 

 

7,281

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

 

2,256

 

 

 

717

 

 

 

(652 )

 

 

1,980

 

 

 

(4,783 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income (expense), net

 

 

1

 

 

 

(1 )

 

 

(10 )

 

 

(9 )

 

 

(35 )

Income from forgiveness of PPP loan

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,698

 

 

 

-

 

Net gain from dissolution of Aehr Test Systems Japan

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,186

 

Other income (expense), net

 

 

10

 

 

 

35

 

 

 

(39 )

 

 

68

 

 

 

(139 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) before income tax (expense) benefit

 

 

2,267

 

 

 

751

 

 

 

(701 )

 

 

3,737

 

 

 

(2,771 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax (expense) benefit

 

 

(24 )

 

 

(34 )

 

 

(34 )

 

 

(81 )

 

 

177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$ 2,243

 

 

$ 717

 

 

$ (735 )

 

$ 3,656

 

 

$ (2,594 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$ 0.08

 

 

$ 0.03

 

 

$ (0.03 )

 

$ 0.14

 

 

$ (0.11 )

Diluted

 

$ 0.08

 

 

$ 0.03

 

 

$ (0.03 )

 

$ 0.13

 

 

$ (0.11 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in per share calculations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

26,871

 

 

 

26,205

 

 

 

23,525

 

 

 

25,684

 

 

 

23,390

 

Diluted

 

 

28,854

 

 

 

28,342

 

 

 

23,525

 

 

 

27,510

 

 

 

23,390

 

 

- more -

 

 

 

Aehr Test Systems Reports Third Quarter Fiscal 2022 Financial Results

March 31, 2022

Page 6 of 7

  

AEHR TEST SYSTEMS AND SUBSIDIARIES

Reconciliation of GAAP and Non-GAAP Results

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

Feb 28,

 

 

Nov 30,

 

 

Feb 28,

 

 

Feb 28,

 

 

Feb 28,

 

 

 

2022

 

 

2021

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income (loss)

 

$ 2,243

 

 

$ 717

 

 

$ (735 )

 

$ 3,656

 

 

$ (2,594 )

Stock-based compensation expense

 

 

880

 

 

 

718

 

 

 

271

 

 

 

2,186

 

 

 

798

 

Excess and obsolesence provision

 

 

1,026

 

 

 

34

 

 

 

104

 

 

 

1,046

 

 

 

117

 

Income from forgiveness of PPP loan

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,698 )

 

 

-

 

Income from disolution of Aehr Test Systesm Japan

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(2,401 )

Non-GAAP net income (loss)

 

$ 4,149

 

 

$ 1,469

 

 

$ (360 )

 

$ 5,190

 

 

$ (4,080 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income (loss) per diluted share

 

$ 0.08

 

 

$ 0.03

 

 

$ (0.03 )

 

$ 0.13

 

 

$ (0.11 )

Non-GAAP net income (loss) per diluted share

 

$ 0.14

 

 

$ 0.05

 

 

$ (0.02 )

 

$ 0.19

 

 

$ (0.17 )

Shares used in GAAP diluted shares calculation

 

 

28,854

 

 

 

28,342

 

 

 

23,525

 

 

 

27,510

 

 

 

23,390

 

Shares used in non-GAAP diluted shares calculation

 

 

28,854

 

 

 

28,342

 

 

 

23,525

 

 

 

27,510

 

 

 

23,390

 

 

 

 

Non-GAAP net income (loss) is a non-GAAP measure and should not be considered a replacement for GAAP results.  Non-GAAP net income (loss) is a financial measure the Company uses to evaluate the underlying results and operating performance of the business.  The limitation of this measure is that it excludes items that impact the Company's current period net income.  This limitation is best addressed by using this measure in combination with net income (loss) (the most directly comparable GAAP financial measure).  These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies.  

 

We believe these measures enhance investors’ ability to review the company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods.   

 

- more -

 

 

 

Aehr Test Systems Reports Third Quarter Fiscal 2022 Financial Results

March 31, 2022

Page 7 of 7

 

AEHR TEST SYSTEMS AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

February 28,

 

 

November 30,

 

 

May 31,

 

 

 

2022

 

 

2021

 

 

2022

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$ 32,020

 

 

$ 35,031

 

 

$ 4,582

 

Accounts receivable, net

 

 

8,543

 

 

 

7,391

 

 

 

5,202

 

Inventories

 

 

14,152

 

 

 

13,033

 

 

 

8,849

 

Prepaid expenses and other

 

 

559

 

 

 

622

 

 

 

551

 

Total current assets

 

 

55,274

 

 

 

56,077

 

 

 

19,184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

776

 

 

 

661

 

 

 

677

 

Operating lease right-of-use assets

 

 

1,091

 

 

 

1,265

 

 

 

1,606

 

Other assets

 

 

214

 

 

 

182

 

 

 

198

 

Total assets

 

$ 57,355

 

 

$ 58,185

 

 

$ 21,665

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$ 3,307

 

 

$ 3,386

 

 

$ 2,893

 

Accrued expenses

 

 

2,535

 

 

 

2,254

 

 

 

2,163

 

Operating lease liabilities, short-term

 

 

778

 

 

 

763

 

 

 

737

 

Customer deposits and deferred revenue, short-term

 

 

6,197

 

 

 

10,142

 

 

 

189

 

Line of credit

 

 

-

 

 

 

-

 

 

 

1,400

 

Current portion of long-term debt

 

 

-

 

 

 

-

 

 

 

1,679

 

Total current liabilities

 

 

12,817

 

 

 

16,545

 

 

 

9,061

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease liabilities, long-term

 

 

415

 

 

 

616

 

 

 

1,007

 

Long-term debt, net of current portion

 

 

-

 

 

 

-

 

 

 

-

 

Deferred revenue, long-term

 

 

90

 

 

 

116

 

 

 

99

 

Other liabilities

 

 

45

 

 

 

46

 

 

 

49

 

Total liabilities

 

 

13,367

 

 

 

17,323

 

 

 

10,216

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total shareholders' equity

 

 

43,988

 

 

 

40,862

 

 

 

11,449

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and shareholders' equity

 

$ 57,355

 

 

$ 58,185

 

 

$ 21,665

 

 

# # #

 

 


The following information was filed by Aehr Test Systems (AEHR) on Thursday, March 31, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Aehr Test Systems's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aehr Test Systems.

Continue

Assess how Aehr Test Systems's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aehr Test Systems's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Revenue
Financial
Other
Filter Subcategory:
All
Product
Income
Earnings
Expense
Geography
Debt
Shares
Other
Inside Aehr Test Systems's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Condensed Consolidated Statements Of Shareholders Equity (Unaudited)
Accounts Receivable (Details Narrative)
Accounts Receivable Net
Basis Of Presentation And Summary Of Significant Acccounting Policies
Basis Of Presentation And Summary Of Significant Acccounting Policies (Policies)
Borrowing And Financing Arrangements
Borrowing And Financing Arrangements (Details Narrative)
Customer Deposits And Deferred Revenue Short-Term
Customer Deposits And Deferred Revenue Short-Term (Tables)
Customer Deposits And Deferred Revenue Shortterm (Details)
Dissolution Of Aehr Test Systems Japan
Dissolution Of Aehr Test Systems Japan (Details Narrative)
Earnings Per Share
Earnings Per Share (Details Narrative)
Earnings Per Share (Details)
Earnings Per Share (Tables)
Equity
Equity (Details Narrative)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Details Narrative)
Fair Value Of Financial Instruments (Details)
Fair Value Of Financial Instruments (Tables)
Income Taxes
Income Taxes (Details Narrative)
Inventories
Inventories (Details Narrative)
Inventories (Details)
Inventories (Tables)
Leases
Leases (Details 1)
Leases (Details Narrative)
Leases (Details)
Leases (Tables)
Longterm Debt
Longterm Debt (Details Narrative)
Product Warranties
Product Warranties (Details Narrative)
Product Warranties (Details)
Product Warranties (Tables)
Recent Accounting Pronouncements
Recent Accounting Pronouncements (Policies)
Revenue
Revenue (Details 1)
Revenue (Details 2)
Revenue (Details Narrative)
Revenue (Details)
Revenue (Tables)
Segment Information
Segment Information (Details Narrative)
Segment Information (Details)
Segment Information (Tables)
Stock-Based Compensation
Stock-Based Compensation (Details 1)
Stock-Based Compensation (Details 2)
Stock-Based Compensation (Details 3)
Stock-Based Compensation (Details 4)
Stock-Based Compensation (Details Narrative)
Stock-Based Compensation (Details)
Stock-Based Compensation (Tables)

Material Contracts, Statements, Certifications & more

Aehr Test Systems provided additional information to their SEC Filing as exhibits

Ticker: AEHR
CIK: 1040470
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-22-004928
Submitted to the SEC: Wed Apr 13 2022 4:13:05 PM EST
Accepted by the SEC: Wed Apr 13 2022
Period: Monday, February 28, 2022
Industry: Instruments For Meas And Testing Of Electricity And Elec Signals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aehr/0001654954-22-004928.htm